1rv1: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1rv1.gif|left|200px]]
{{Seed}}
[[Image:1rv1.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1rv1|  PDB=1rv1  |  SCENE=  }}  
{{STRUCTURE_1rv1|  PDB=1rv1  |  SCENE=  }}  


'''CRYSTAL STRUCTURE OF HUMAN MDM2 WITH AN IMIDAZOLINE INHIBITOR'''
===CRYSTAL STRUCTURE OF HUMAN MDM2 WITH AN IMIDAZOLINE INHIBITOR===




==Overview==
<!--
MDM2 binds the p53 tumor suppressor protein with high affinity and negatively modulates its transcriptional activity and stability. Overexpression of MDM2, found in many human tumors, effectively impairs p53 function. Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy. Here, we identify potent and selective small-molecule antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes. These compounds bind MDM2 in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice.
The line below this paragraph, {{ABSTRACT_PUBMED_14704432}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 14704432 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_14704432}}


==About this Structure==
==About this Structure==
Line 28: Line 32:
[[Category: P53]]
[[Category: P53]]
[[Category: Protein-protein interaction]]
[[Category: Protein-protein interaction]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 07:56:41 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 21:12:44 2008''